Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02646930 · ClinicalTrials.gov registry record · NA

Chronic Endometritis and IVF

A NA study of in Vitro Fertilization and Chronic Endometritis, sponsored by Duke University.

Completed
Registry status
NA
Development phase
57
Enrollment target
2
Study locations

NCT02646930: Completed NA study of in Vitro Fertilization and Chronic Endometritis, sponsored by Duke University.

NCT02646930 is a NA study of in Vitro Fertilization and Chronic Endometritis that has completed, run by Duke University. The registered enrollment target is 57 participants, below the 627-participant average among 3 other in Vitro Fertilization trials with a reported enrollment target (91% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02646930, a NA study of in Vitro Fertilization and Chronic Endometritis, has completed, sponsored by Duke University.

COMPLETED
Registry status
NA
Development phase
57 participants
Enrollment target
2
Study locations

Study Summary

Background: Embryo quality is known to be a very important determinant to predict the implantation and pregnancy rate in IVF patients, however, the role of uterine integrity or endometrial receptivity cannot be overlooked. Chronic endometritis (CE) is an inflammation of the endometrium diagnosed by the presence of plasma cells in the endometrial stroma. There is not only no census on the definition of CE, the current literature on the impact of CE on reproductive outcome is controversial and consists only of retrospective studies with small sample sizes. Although there is a presumption that CE is related to poor IVF outcome, this belief has not been proven. Design: Prospective cohort study Setting: Infertility clinics of 2 academic medical centers Patients: Patients between the ages of ≥ 21 and ≤ 35 years old undergoing their first IVF cycle will be invited to participate. Main Outcome Measures: The primary outcome will be ongoing pregnancy after 12 weeks estimated gestational age (EGA) with previously documented fetal cardiac motion. Secondary outcomes will include pregnancy loss rate as defined by chemical pregnancy, blighted ovum or loss of fetal cardiac motion before 12 weeks EGA. Materials and Methods: The cycle prior to IVF, patients will undergo an in-office endometrial biopsy on cycle days 19-24. Samples will be stained for CD138 and the number of plasma cells will be quantified. The number of plasma cells in a sample that yields the best sensitivity and specificity for pregnancy will be determined by a Receiver-Operator-Curve. This number will then be used as a dichotomous variable to assign categories of "positive for CE" and "negative for CE." Pregnancy and miscarriage rates will then be determined in the positive and negative CE sample with Chi Square Analysis. A secondary sub analysis will be performed to determine pregnancy and miscarriage rates in patients who declined to participate in the study. Expected Results: The investigators hypothesize

Interventions

  • PROCEDURE Endometrial biopsy

Study Locations (2)

Illinois

  • University of Illinois - Chicago

North Carolina

  • Duke Fertility Clinic - Durham

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2016-03-03
Est. Completion 2019-05-16
Phase NA
Duke University

1,725 total trials

What the finished NCT02646930 record still lists

NCT02646930 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 627-participant average among 3 other in Vitro Fertilization trials with a reported enrollment target (91% lower).

The record links to 2 conditions, with in Vitro Fertilization appearing as the primary indexed condition, and to 1 intervention - of which Endometrial biopsy is the first listed.

NCT02646930 reports a single indexed study location in Illinois, North Carolina.

Frequently Asked Questions

What is clinical trial NCT02646930 about?

NCT02646930 is a clinical study titled "Chronic Endometritis and IVF". Background: Embryo quality is known to be a very important determinant to predict the implantation and pregnancy rate in IVF patients, however, the role of uterine integrity or endometrial receptivity cannot be overlooked. Chronic endometritis (CE) is an inflammation of the endometrium diagnosed by...

What is the current status of trial NCT02646930?

This trial is currently completed. It is a NA study. The enrollment target is 57 participants. The study started on 2016-03-03. Estimated completion is 2019-05-16.

What conditions does trial NCT02646930 study?

This clinical trial studies the following conditions: in Vitro Fertilization, Chronic Endometritis.

What interventions are being tested in trial NCT02646930?

The interventions under investigation include: Endometrial biopsy (PROCEDURE).

Who is sponsoring clinical trial NCT02646930?

This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02646930 being conducted?

This trial has 2 study locations across Illinois, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for in Vitro Fertilization

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03521830 · 57 participants · Phase 2

    Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma

  • NCT03587701 · 57 participants · Phase 2

    Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease

  • NCT04104126 · 57 participants · NA

    Blood Flow Restriction Therapy in Achilles Injury

  • NCT04703842 · 57 participants · Phase 1

    Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02646930, the US trial registry maintained by the National Library of Medicine. NCT02646930 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.